GLOW – 70mg

GLOW

(also known as the GLOW Blend or GLOW Stack) is a highly specialized, multi-peptide research formulation combining three synergistic compounds: GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg). Rather than a single novel molecule, this pre-mixed combination is engineered to study coordinated cellular signaling across multiple pathways simultaneously. By grouping an extracellular matrix modulator with two potent tissue-repair peptides, the GLOW blend provides researchers with an all-in-one matrix environment to observe advanced cellular regeneration, collagen synthesis, and anti-inflammatory mechanisms in laboratory models. [1, 2, 3, 4]

Key Features & Characteristics

• Combinatorial Composition: Delivers a precise ratio of GHK-Cu, BPC-157, and TB-500 in a single vial to streamline multi-variable experimental testing. [1, 2]
• Dual-Phase Tissue Repair: Merges the systemic angiogenic properties of BPC-157 with the actin-sequestering, cell-migration properties of TB-500. [1, 2]
• Structural Matrix Signaling: Leverages GHK-Cu’s high copper-chelation capacity to prompt fibroblast activity and upregulate structural protein transcription. [1, 2]
• Physical Form: Provided as a co-lyophilized, ultra-pure powder that typically exhibits a light blue tint due to the presence of copper tripeptide. [1, 2, 3]

Primary Research Applications

• Extracellular Matrix Remodeling: Heavily studied in tissue engineering models to investigate changes in skin thickness, elastin production, and the structural density of collagen fibers.
• Accelerated Wound & Scar Healing: Investigated in acute and chronic injury models to track how the compound minimizes scar tissue formation and speeds up epidermal repair.
• Anti-Inflammatory Cascades: Evaluated for its potential to downregulate pro-inflammatory cytokines, calm localized tissue stress, and protect compromised cellular structures. [1, 2, 3]

For Research Use Only. Not for human consumption, therapeutic, or diagnostic use. [1]